Beware ‘One Size Fits All’ Thinking on Carbohydrates and Cardiometabolic Health

New review sorts evidence from overgeneralizations

21-HVI-2104549_carbohydrate-grains-fiber_650x450

When it comes to teasing out the effects of dietary carbohydrate intake on cardiometabolic health, the devil is very much in the details, and more details are needed for conclusions on some important questions. That’s an overarching message of a new evidence-based review of the topic published in Atherosclerosis (Epub March 27, 2021) by Cleveland Clinic cardiologist Leslie Cho, MD, and two European colleagues.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

“Carbohydrates have been vilified in the media over the past two decades, often due to overbroad generalizations not supported by evidence,” says Dr. Cho, Co-Section Head of Preventive Cardiology and Rehabilitation. “The recent prominence of high-protein diets for weight loss has fueled further confusion, leading too many people to overlook the essential role carbohydrates play in a healthy diet.”

Analyzing a range of effects

Together with expert nutrition and health researchers from the Netherlands and Italy, Dr. Cho reviewed the latest evidence — almost exclusively from observational studies and meta-analyses of intervention studies — on the effect of fiber, whole grain and refined carbohydrates on the following:

  • Weight
  • Insulin resistance
  • Diabetes
  • Inflammation
  • Lipids
  • Long-term rates of major cardiac events
  • All-cause mortality

They begin by noting that current understanding of carbohydrates’ health effects has been hindered by the traditional limitations of dietary recall studies and the fact that many studies to date have failed to differentiate among the various types of carbohydrates.

“Carbohydrates may be thought of in terms of complex versus simple and then further broken down into fiber, starches and sugar,” notes Dr. Cho, the paper’s corresponding author.

Advertisement

Accordingly, the paper proceeds to review the latest evidence from clinical studies in three main sections:

  • Fiber and whole grain
  • Refined carbohydrates
  • Epidemiological studies of carbohydrates with mortality

A sampling of key conclusions

The review leads the authors to a number of conclusions, including the following:

  • High consumption of dietary fiber and whole grains is associated with positive effects on metabolic health, whereas high consumption of sugar and refined carbohydrates has negative effects on cardiometabolic health.
  • Carbohydrate type is also critical to clinical outcomes, with diets rich in fiber and whole grains associated with lower rates of mortality and cardiovascular events.
  • Evidence consistently shows that low-fat and low-carbohydrate diets yield comparable effects on body weight, assuming comparable energy levels.
  • The jury is still out on how a low-carbohydrate diet impacts diabetes control. Whereas short-term studies have demonstrated better fasting glucose and lower hemoglobin A1c, these benefits in diabetes control attenuated with longer follow-up.

“The quality of the carbohydrate dictates its effect on both cardiometabolic health and cardiovascular events,” observes Dr. Cho. “Moreover, individuals’ responses to dietary fiber interventions are likely determined by their initial microbial and/or metabolic phenotype. It’s becoming more and more clear that this is not a one-size-fits-all question.”

In fact, the review authors identify the impact of individual traits and lifestyle factors on the effectiveness of fiber interventions as a priority for future research. Another priority focus is the role played by regional and ethnic differences in various metabolic and clinical outcomes of the consumption of differing types of carbohydrates. And the authors note that because most data to date are from observational studies, definitive evidence on the benefits and adverse effects of various carbohydrate types is lacking.

Advertisement

New tech tools, and a near-term call to action

The review authors note that the emergence of mobile app-enabled patient-entered diet data should help bolster the number and quality of dietary and intervention studies to start filling these knowledge gaps. “A revolution in dietary research may be at hand, thanks to the power of patient-entered data along with evolving insights into the impact of the gut microbiome,” says Dr. Cho.

In the meantime, despite the considerable remaining uncertainties, she believes there’s enough clarity to make a broad recommendation for present action. “At a global level, most people consume less than 20 grams of fiber daily while consuming a large quantity of refined carbohydrates,” Dr. Cho notes. “The current evidence fully justifies additional measures to enhance the amount and diversity of fiber consumption worldwide while simultaneously reducing intake of refined carbohydrates.”

The review paper is available here.

Related Articles

older woman using computer
Web App Enables Safe, Effective Nonprescription Statin Use

Tech-assisted self-selection concurred with clinician-assessed eligibility in >90% of cases

photo of grains and niacin supplement pills
Link Discovered Between Excess Niacin and Cardiovascular Disease

Newly identified pathway may explain the so-called niacin paradox

19-HVI-1792159; Steven Nissen, M.D., M.A.C.C.; Mike Viars
Lipoprotein(a): Progress on One of the Last Untreatable Frontiers of Cardiovascular Risk

It's time to increase testing for this major cardiovascular risk factor in advance of new therapies

illustration showing action of a GLP-1 receptor agonist
Semaglutide Shows Secondary Cardiovascular Prevention Benefits in Patients Without Diabetes

Findings establish overweight/obesity as a modifiable risk factor for cardiovascular disease

23-HVI-4317309_lipoprotein(a)_650x450
Novel siRNA Reduces Lipoprotein(a) by More Than 90% for 48 Weeks

Undetectable levels achieved for nearly nine months in phase 1 trial

illustration of coronary artery with calcified plaque
Coronary Artery Calcium Scoring Improves Accuracy of Cardiovascular Risk Screening

Observational study supports adding CAC score to traditional risk factors for precision medicine approach

Middle-aged overweight Hispanic woman having her blood pressure checked
Lorundrostat Safely Lowers Blood Pressure in Uncontrolled Hypertension in Phase 2 Trial

Results inform dose selection for further trials of the aldosterone synthase inhibitor

23-HVI-3606662_calcium-scoring_650x450
Coronary Artery Calcium Correlates With Carotid Plaque but Not Significant Carotid Stenosis

Retrospective findings from an executive health program spur interest in broader studies

Ad